Skip to content

Clinical Validation of New Commercial Sleep Monitoring Devices

Clinical Validation of New Commercial Sleep Monitoring Devices

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02779543
Enrollment
200
Registered
2016-05-20
Start date
2018-06-01
Completion date
2018-07-30
Last updated
2019-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea

Keywords

In lab sleep studies

Brief summary

This study seeks to validate three new commercial sleep monitoring devices: Fitbit, Jawbone UP, and Microsoft Band by comparison against concurrent polysomnography (PSG), which is considered the gold standard for sleep assessment. This research is being done because if proven to accurately analyze sleep,these devices may make conducting in-home sleep studies easier and more affordable in the future.

Detailed description

This study seeks to validate three new commercial sleep monitoring devices: Fitbit, Jawbone UP, and Microsoft Band by comparison against concurrent polysomnography (PSG), considered the gold standard assessment for sleep physiology. The investigators emphasize here that the commercial sleep monitoring devices (Fitbit, Jawbone UP, and Microsoft Band) are used in addition to PSG and not in place of it. Subjects will be recruited from those patients attending a regularly scheduled overnight PSG sleep study at the Weill Cornell Medical College Center for Sleep Medicine. Willing subjects, after providing informed consent, will be fitted with one of the three aforementioned sleep monitoring devices (randomly assigned) on the wrist of their non-dominant hand when prepared for the sleep study by a technician. Subjects willing to wear more than one sleep monitoring device may be fitted with two different sleep monitoring devices, e.g., a Fitbit and a Jawbone UP or a Fitbit and a Microsoft Band. Sleep monitoring device(s) will be removed from the subject's wrist in the morning at the conclusion of the sleep study. Data will be transferred from the sleep monitoring device(s) for later statistical analysis and comparison with scored polysomnogram. Device(s) will be cleaned (using antiseptic wipes), reset,recharged, and otherwise prepared for reuse.

Interventions

DEVICEFitbit

Subjects will be recruited from those patients attending a regularly scheduled overnight PSG sleep study at the Weill Cornell Medical College Center for Sleep Medicine. Willing subjects, after providing informed consent, will be fitted with one of the three aforementioned sleep monitoring devices (randomly assigned) on the wrist of their non-dominant hand when prepared for the sleep study by a technician.

Subjects will be recruited from those patients attending a regularly scheduled overnight PSG sleep study at the Weill Cornell Medical College Center for Sleep Medicine. Willing subjects, after providing informed consent, will be fitted with one of the three aforementioned sleep monitoring devices (randomly assigned) on the wrist of their non-dominant hand when prepared for the sleep study by a technician.

DEVICEMicrosoft Band

Subjects will be recruited from those patients attending a regularly scheduled overnight PSG sleep study at the Weill Cornell Medical College Center for Sleep Medicine. Willing subjects, after providing informed consent, will be fitted with one of the three aforementioned sleep monitoring devices (randomly assigned) on the wrist of their non-dominant hand when prepared for the sleep study by a technician.

Sponsors

Cornell University
CollaboratorOTHER
Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Attending a regularly scheduled overnight polysomnography (PSG) sleep study at the Weill Cornell Medical College Center for Sleep Medicine.

Exclusion criteria

* Not attending a regularly scheduled overnight polysomnography (PSG) sleep study at the Weill Cornell Medical College Center for Sleep Medicine. * Under 18 or over 80 years old. * Pregnancy * Unable to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Total Sleep Time as Measured by Fitbit Charge2 or Microsoft Band2.1 night, approximately 9 hours.Statistical analysis will examine agreement levels of sleep metrics such as Total Sleep Time (TST).

Secondary

MeasureTime frameDescription
Sleep Onset Latency as Measured by Fitbit Charge2 or Microsoft Band2.1 night, approximately 9 hours.Statistical analysis will examine agreement levels of sleep metrics such as Sleep Onset Latency (SOL).
Wake Time After Sleep Onset as Measured by Fitbit Charge2 or Microsoft Band2.1 night, approximately 9 hours.Statistical analysis will examine agreement levels of sleep metrics such as Wake After Sleep Onset (WASO)
Sleep Efficiency as Measured by Fitbit Charge2 or Microsoft Band2.1 night, approximately 9 hours.Statistical analysis will examine agreement levels of sleep metrics such as Sleep Efficiency (SE)

Countries

United States

Participant flow

Participants by arm

ArmCount
Fitbit Charge 2
Willing subjects, after providing informed consent, will be fitted with Fitbit Charge 2 on the wrist of their non dominant hand when prepared for the sleep study by a technician. Sleep monitoring device(s) will be removed from the subject's wrist in the morning at the conclusion of the sleep study. Fitbit: Subjects will be recruited from those patients attending a regularly scheduled overnight PSG sleep study at the Weill Cornell Medical College Center for Sleep Medicine.
100
Microsoft Band 2
Willing subjects, after providing informed consent, will be fitted with Microsoft Band 2 on the wrist of their non dominant hand when prepared for the sleep study by a technician. Sleep monitoring device(s) will be removed from the subject's wrist in the morning at the conclusion of the sleep study. Microsoft Band 2: Subjects will be recruited from those patients attending a regularly scheduled overnight PSG sleep study at the Weill Cornell Medical College Center for Sleep Medicine.
100
Total200

Baseline characteristics

CharacteristicFitbit Charge 2Microsoft Band 2Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
37 Participants25 Participants62 Participants
Age, Categorical
Between 18 and 65 years
63 Participants75 Participants138 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
100 Participants100 Participants200 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
United States
100 participants100 participants200 participants
Sex: Female, Male
Female
42 Participants39 Participants81 Participants
Sex: Female, Male
Male
58 Participants61 Participants119 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1000 / 100
other
Total, other adverse events
0 / 1000 / 100
serious
Total, serious adverse events
0 / 1000 / 100

Outcome results

Primary

Total Sleep Time as Measured by Fitbit Charge2 or Microsoft Band2.

Statistical analysis will examine agreement levels of sleep metrics such as Total Sleep Time (TST).

Time frame: 1 night, approximately 9 hours.

ArmMeasureValue (MEAN)Dispersion
Fitbit Charge 2Total Sleep Time as Measured by Fitbit Charge2 or Microsoft Band2.437.0 minutesStandard Deviation 80.6
Microsoft Band 2Total Sleep Time as Measured by Fitbit Charge2 or Microsoft Band2.394.9 minutesStandard Deviation 105.8
p-value: <0.001ANOVA
Secondary

Sleep Efficiency as Measured by Fitbit Charge2 or Microsoft Band2.

Statistical analysis will examine agreement levels of sleep metrics such as Sleep Efficiency (SE)

Time frame: 1 night, approximately 9 hours.

ArmMeasureValue (MEAN)Dispersion
Fitbit Charge 2Sleep Efficiency as Measured by Fitbit Charge2 or Microsoft Band2.93.4 percentage of sleep efficiencyStandard Deviation 9.6
Microsoft Band 2Sleep Efficiency as Measured by Fitbit Charge2 or Microsoft Band2.82.1 percentage of sleep efficiencyStandard Deviation 15.5
p-value: <0.001ANOVA
Secondary

Sleep Onset Latency as Measured by Fitbit Charge2 or Microsoft Band2.

Statistical analysis will examine agreement levels of sleep metrics such as Sleep Onset Latency (SOL).

Time frame: 1 night, approximately 9 hours.

ArmMeasureValue (MEAN)Dispersion
Fitbit Charge 2Sleep Onset Latency as Measured by Fitbit Charge2 or Microsoft Band2.8.8 minutesStandard Deviation 13.7
Microsoft Band 2Sleep Onset Latency as Measured by Fitbit Charge2 or Microsoft Band2.26.2 minutesStandard Deviation 30.5
p-value: <0.001ANOVA
Secondary

Wake Time After Sleep Onset as Measured by Fitbit Charge2 or Microsoft Band2.

Statistical analysis will examine agreement levels of sleep metrics such as Wake After Sleep Onset (WASO)

Time frame: 1 night, approximately 9 hours.

ArmMeasureValue (MEAN)Dispersion
Fitbit Charge 2Wake Time After Sleep Onset as Measured by Fitbit Charge2 or Microsoft Band2.30.3 minutesStandard Deviation 42
Microsoft Band 2Wake Time After Sleep Onset as Measured by Fitbit Charge2 or Microsoft Band2.88.0 minutesStandard Deviation 71.7
p-value: <0.001ANOVA

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026